Dudley & Shanley’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.97M Buy
+165,000
New +$4.32M 0.6% 31
2022
Q4
Sell
-6,000
Closed -$263K 35
2022
Q3
$263K Hold
6,000
0.07% 26
2022
Q2
$315K Hold
6,000
0.07% 28
2022
Q1
$311K Hold
6,000
0.06% 30
2021
Q4
$354K Hold
6,000
0.06% 32
2021
Q3
$258K Hold
6,000
0.05% 31
2021
Q2
$235K Hold
6,000
0.04% 31
2021
Q1
$217K Buy
+6,000
New +$213K 0.04% 30

Other funds holding PFE

Dudley & Shanley's PFE Position: Q2 2026 in Review

Dudley & Shanley opened a new position in Pfizer (PFE) in Q2 2026: 165,000 shares worth $3.97M. The stake represents 0.6% of the portfolio and ranks #31 among its holdings. This is a return to the name: Dudley & Shanley previously reported a position in PFE as recently as Q3 2022.

Dudley & Shanley first reported a position in PFE in Q1 2021 and has held it in 8 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Dudley & Shanley held 165,000 shares of Pfizer worth $3.97M as of Q2 2026.
  • Pfizer was a new Dudley & Shanley position in Q2 2026.
  • Pfizer made up 0.6% of Dudley & Shanley's portfolio in Q2 2026, its #31 holding.
  • Dudley & Shanley first reported a position in Pfizer in Q1 2021 and has held it in 8 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Dudley & Shanley's 13F filing for Q2 2026, filed 9 Jul 2026.